Cor Vasa 2009, 51(1):13-18 | DOI: 10.33678/cor.2009.006
Effect of secondary prevention on all-cause mortality in Czech survivors of myocardial infarction: a population-based study
- 1 Laboratory for Atherosclerosis Research, Institute for Clinical and Experimental Medicine, Prague
- 2 Department of Diabetology, Litomerice District Hospital, Litomerice, Czech Republic
- 3 Cardiovascular Research Institute and Department of Medicine, University of California San Francisco, USA
- 4 Department of Medical Informatics, Institute of Computer Science AS CR, Prague, Czech Republic
Background: In spite of successful introduction of interventional treatment of acute coronary syndromes in Czech Republic, recent surveys show that coronary intervention and drug therapies need to be combined with a lifestyle and risk factor intervention. We assessed the effect of intervention after myocardial infarction targeting multiple risk factors in a high-risk population with limited access to hypolipidemic drugs and revascularization.
Methods: In 1992-1993, we enrolled all men under age 60 (n = 68) and all women under age 65 (n = 40) who survived myocardial infarction and were discharged from a single coronary care unit in an 18-month intervention program targeting dyslipidemia, smoking and highly saturated fats diet. Thirty % were diabetic and 46% of the remainder fulfilled ATP III criteria for the metabolic syndrome.
Results: After one year, non-HDL cholesterol fell by 27%, smoking from 47% to 16%, and diet scores were substantially improved. As compared with a control population of 96 patients discharged from this CCU during the same period in 1990-1991, all-cause mortality in men was significantly reduced over 2.6 years (hazard ratio ranging from 0.083 to 0.18) and remained lower over 6.7 years of maximum follow-up. Among women, all-cause mortality was not significantly changed by the intervention.
Conclusion: Multifactor intervention after myocardial infarction in men under age 60 with limited access to revascularization procedures dramatically reduced all-cause mortality for 2.6 years.
Keywords: Secondary prevention; Myocardial infarction; Metabolic syndrome; Diabetes mellitus
Published: January 1, 2009 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Widimsky P, Zelizko M, Jansky P, Tousek F, Holm F, Aschermann M. CZECH investigators. The incidence, treatment strategies and outcomes of acute coronary syndromes in the "reperfusion network" of different hospital types in the Czech Republic: results of the Czech evaluation of acute coronary syndromes in hospitalized patients (CZECH) registry. Int J Cardiol 2007;119: 212-9.
Go to original source...
Go to PubMed...
- Kindermann M, Adam O, Werner N, Böhm M. Clinical Trial Updates and Hotline Sessions presented at the European Society of Cardiology Congress 2007: (FINESSE, CARESS, OASIS 5, PRAGUE-8, OPTIMIST, GRACE, STEEPLE, SCAAR, STRATEGY, DANAMI-2, ExTRACT-TIMI-25, ISAR-REACT 2, ACUITY, ALOFT, 3CPO, PROSPECT, EVEREST, COACH, BENEFiT, MERLIN-TIMI 36, SEARCH-MI, ADVANCE, WENBIT, EUROASPIRE I-III, ARISE, getABI, RIO). Clin Res Cardiol 2007;96:767-86.
Go to original source...
Go to PubMed...
- Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 203;348:383-93.
- Sdringola S, Nakagawa K, Nakagawa Y, et al. Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual-care cholesterol-lowering drugs in coronary artery disease. J Am Coll Cardiol 2003;41:263-72.
Go to original source...
- Uemura K, Pisa Z. Trends in cardiovascular disease mortality in industrialized countries since 1950. World Health Stat Q 1988;41:155-78.
- Skodova Z, Pisa Z, Vojtisek P, et al. Changes in the cardiovascular risk profile of the population of the Czech Republic-MONICA 1992. Cas Lek Ces 1994;133:624-6.
- EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group European Action on Secondary Prevention through Intervention to Reduce Events. Eur Heart J 1997;18:1569-82. Erratum in (1998) Eur Heart J 1998;19;356-7.
Go to PubMed...
- EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J 2001;22:554-72.
Go to original source...
Go to PubMed...
- Multinational monitoring of trends and determinants in cardiovascular disease - MONICA Project Manual of operations 1983; WHO/MNC:82.2.
- Peters JR, Quiter ES, Brekke ML, et al. The Eating Pattern Assessment Tool: A simple instrument for assessing dietary fat and cholesterol intake. J Am Dietetic Assoc 1994;94:1008-13.
Go to original source...
Go to PubMed...
- Havel RJ, Rapaport E. Management of primary hyperlipidemia. N Engl J Med 1995;332:1491-8.
Go to original source...
Go to PubMed...
- National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-221.
Go to original source...
- Gray RJ. Spline-based tests in survival analysis. Biometrics 1994;50:640-52.
Go to original source...
Go to PubMed...
- Gray RJ. Flexible methods for analyzing survival data using splines, with application to breast cancer prognosis. J Am Statistical Assoc 1994;87:942-51.
Go to original source...
- Cox DR. Regression models and life-tables (with discussion). J Royal Statistical Society. Series B. Methodological 1972;34:187-220.
Go to original source...
- Bruthans J. Report on Development of Cardiovascular Diseases in the Czech Republic after 1989. Prague: Galen, 2000:180.
- Rosolová H, Mayer O Jr, Simon J, Sefrna F. Detection of risk of insulin resistance in the population. Cas Lek Ces 1998;137:80-3.
- Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease. JAMA 2003;290:86-97.
Go to original source...
Go to PubMed...
- Reaven G, Tsao PS. Insulin resistance and compensatory hyperinsulinemia: the key player between cigarette smoking and cardiovascular disease? J Am Coll Cardiol 2003;41:1044-7.
Go to original source...
- Poledne R, Skodova Z. Changes in nutrition, cholesterol concentration, and cardiovascular disease mortality in the Czech population in the past decade. Nutrition 2000;16:785-6.
Go to original source...
Go to PubMed...
- Goldberg RJ, Steg PG, Sadiq I, et al. Extent of, and factors associated with, delay to hospital presentation in patients with acute coronary disease (the GRACE registry). Am J Cardiol 2002;89:791-6.
Go to original source...
- Bouma J, Broer J, Bleeker J, van Sonderen E, Meyboom-de Jong B, DeJongste MJ. Longer pre-hospital delay in acute myocardial infarction in women because of longer doctor decision time. J Epidemiol Community Health 1999;53:459-64.
Go to original source...